Home / SME Stocks / Curis Lifesciences
Curis Lifesciences: IPO, Share Price and Results Since Listing
Curis Lifesciences listed on NSE Emerge on 14 November 2025 after an IPO at INR 128 a share. On 11 November 2026 the shares closed at INR 170.70, 33.36% above the issue price. For H2 FY2026 it reported revenue of INR 32.72 crore and a profit after tax of INR 2.71 crore.
Key Facts
- IPO dates
- 7 November 2025 to 11 November 2025
- Issue price
- INR 128
- Issue size
- INR 27.52 crore
- Subscription
- 74.47 times
- Lead manager
- Finaax Capital Advisors Private Limited
- Listing day
- opened at INR 146.10 (+14.14%), closed at INR 141 (+10.16%)
- Listed on NSE Emerge
- 14 November 2025
- Symbol
- CURIS
- Latest close
- INR 170.70 on 11 November 2026
- Against issue price
- +33.36%
- Lot size now
- 1,000 shares (INR 1,70,700 at the latest close)
Results Filed With NSE
Standalone figures, INR crore. Change compares with the same period a year earlier.
| Period | Revenue | Change | Profit after tax | EPS (INR) | Filed | |
|---|---|---|---|---|---|---|
| H2 FY2026 | 32.72 | – | 2.71 | 4.01 | after listing | 7 July 2026 |
| FY2026 | 60.63 | – | 6.92 | 10.26 | after listing | 7 July 2026 |
| H1 FY2026 | 27.91 | – | 4.21 | 7.10 | before listing | 8 December 2025 |
Promoter Holding
Promoter holding has moved from 68.03% on 12 November 2025 to 68.03% on 30 September 2026 (0 percentage points).
| As of | Promoters | Public |
|---|---|---|
| 30 September 2026 | 68.03% | 31.97% |
| 31 March 2026 | 68.03% | 31.97% |
| 12 November 2025 | 68.03% | 31.97% |
Anchor Lock-ins
| Lock-in | Ends |
|---|---|
| 30 days | 12 December 2025 |
| 90 days | 10 February 2026 |
Sources: NSE Emerge filings (results XBRL, shareholding pattern, board meetings), NSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.